RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Diagnostic evaluation of qRT-PCR-based kit and dPCR-based kit for COVID-19

      한글로보기

      https://www.riss.kr/link?id=A107914964

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background Coronavirus disease of 2019 (COVID-19) is well known as a fatal disease, frst discovered at Wuhan in China, ranging from mild to death, such as shortness of breath and fever. Early diagnosis of COVID-19 is a crucial point in preventing global prevalence.
      Objective We aimed to evaluate the diagnostic competency and efciency with the Allplex™ 2019-nCoV Assay kit and the Dr. PCR 20 K COVID-19 Detection kit, designed based on the qRT-PCR and dPCR technologies, respectively.
      Methods A total of 30 negative and 20 COVID-19 positive specimens were assigned to the diagnostic test by using different COVID-19 diagnosis kits. Diagnostic accuracy was measured by statistical testing with sensitivity, specifcity, and co-efciency calculations.
      Results Comparing both diagnostic kits, we confrmed that the diagnostic results of 30 negative and 20 positive cases were the same pre-diagnostic results. The diagnostic statistics test results were perfectly matched with value (1). Cohen’s Kappa coefcient was demonstrated that the given kits in two diferent ways were “almost perfect” with value (1). In evaluating the detection capability, the dilutional linearity experiments substantiate that the Dr. PCR 20 K COVID-19 Detection kit could detect SARS-CoV-2 viral load at a concentration ten times lower than that of the Allplex™ 2019-nCoV Assay kit.
      Conclusions In this study, we propose that the dPCR diagnosis using LOAA dPCR could be a powerful method for COVID19 point-of-care tests requiring immediate diagnosis in a limited time and space through the advantages of relatively low sample concentration and small equipment size compared to conventional qRT-PCR.
      번역하기

      Background Coronavirus disease of 2019 (COVID-19) is well known as a fatal disease, frst discovered at Wuhan in China, ranging from mild to death, such as shortness of breath and fever. Early diagnosis of COVID-19 is a crucial point in preventing glob...

      Background Coronavirus disease of 2019 (COVID-19) is well known as a fatal disease, frst discovered at Wuhan in China, ranging from mild to death, such as shortness of breath and fever. Early diagnosis of COVID-19 is a crucial point in preventing global prevalence.
      Objective We aimed to evaluate the diagnostic competency and efciency with the Allplex™ 2019-nCoV Assay kit and the Dr. PCR 20 K COVID-19 Detection kit, designed based on the qRT-PCR and dPCR technologies, respectively.
      Methods A total of 30 negative and 20 COVID-19 positive specimens were assigned to the diagnostic test by using different COVID-19 diagnosis kits. Diagnostic accuracy was measured by statistical testing with sensitivity, specifcity, and co-efciency calculations.
      Results Comparing both diagnostic kits, we confrmed that the diagnostic results of 30 negative and 20 positive cases were the same pre-diagnostic results. The diagnostic statistics test results were perfectly matched with value (1). Cohen’s Kappa coefcient was demonstrated that the given kits in two diferent ways were “almost perfect” with value (1). In evaluating the detection capability, the dilutional linearity experiments substantiate that the Dr. PCR 20 K COVID-19 Detection kit could detect SARS-CoV-2 viral load at a concentration ten times lower than that of the Allplex™ 2019-nCoV Assay kit.
      Conclusions In this study, we propose that the dPCR diagnosis using LOAA dPCR could be a powerful method for COVID19 point-of-care tests requiring immediate diagnosis in a limited time and space through the advantages of relatively low sample concentration and small equipment size compared to conventional qRT-PCR.

      더보기

      참고문헌 (Reference)

      1 Kumar A, "Wuhan to World : the COVID-19 pandemic" 11 : 596201-, 2021

      2 Chung YS, "Validation of real-time RT-PCR for detection of SARS-CoV-2 in the early stages of the COVID-19 outbreak in the Republic of Korea" 11 : 14817-, 2021

      3 Cascella M, "StatPearls" 2021

      4 Ambrosi C, "SARS-CoV-2 : comparative analysis of diferent RNA extraction methods" 287 : 114008-, 2021

      5 Murphy J, "Reliability of real-time reverse-transcription PCR in clinical diagnostics : gold standard or substandard?" 9 : 187-197, 2009

      6 Gupta N, "Point-of-care PCR assays for COVID-19 detection" 11 : 141-, 2021

      7 Park J, "Learning from past pandemic governance : early response and public-private partnerships in testing of COVID-19in South Korea" 137 : 105198-, 2021

      8 Goudouris ES, "Laboratory diagnosis of COVID-19" 97 : 7-12, 2021

      9 Watson J, "Interpreting a covid-19 test result" 369 : m1808-, 2020

      10 Lai CC, "In vitro diagnostics of coronavirus disease 2019 : technologies and application" 54 : 164-174, 2021

      1 Kumar A, "Wuhan to World : the COVID-19 pandemic" 11 : 596201-, 2021

      2 Chung YS, "Validation of real-time RT-PCR for detection of SARS-CoV-2 in the early stages of the COVID-19 outbreak in the Republic of Korea" 11 : 14817-, 2021

      3 Cascella M, "StatPearls" 2021

      4 Ambrosi C, "SARS-CoV-2 : comparative analysis of diferent RNA extraction methods" 287 : 114008-, 2021

      5 Murphy J, "Reliability of real-time reverse-transcription PCR in clinical diagnostics : gold standard or substandard?" 9 : 187-197, 2009

      6 Gupta N, "Point-of-care PCR assays for COVID-19 detection" 11 : 141-, 2021

      7 Park J, "Learning from past pandemic governance : early response and public-private partnerships in testing of COVID-19in South Korea" 137 : 105198-, 2021

      8 Goudouris ES, "Laboratory diagnosis of COVID-19" 97 : 7-12, 2021

      9 Watson J, "Interpreting a covid-19 test result" 369 : m1808-, 2020

      10 Lai CC, "In vitro diagnostics of coronavirus disease 2019 : technologies and application" 54 : 164-174, 2021

      11 Dong LH, "Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR" 224 : 121726-, 2021

      12 Syal K, "Guidelines on newly identifed limitations of diagnostic tools for COVID-19 and consequences" 93 : 1837-1842, 2021

      13 Lee CY, "Fluorescence polarization system for rapid COVID-19 diagnosis" 178 : 113049-, 2021

      14 Lin L, "Experience with false-positive test results on the TaqPath realtime reverse transcription-polymerase chain reaction Coronavirus Disease 2019(COVID-19)testing platform" 145 : 259-261, 2021

      15 Garg A, "Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens" 93 : 2281-2286, 2021

      16 Daly CH, "Empirical evaluation of SUCRA-based treatment ranks in network meta-analysis : quantifying robustness using Cohen’s kappa" 9 : e024625-, 2019

      17 Freppel W, "Efcient SARSCoV-2 detection in unextracted oro-nasopharyngeal specimens by rRT-PCR with the Seegene Allplex(TM)2019-nCoV assay" 17 : 196-, 2020

      18 Peck KR, "Early diagnosis and rapid isolation : response to COVID-19 outbreak in Korea" 26 : 805-807, 2020

      19 van Stralen KJ, "Diagnostic methods I : sensitivity, specifcity, and other measures of accuracy" 75 : 1257-1263, 2009

      20 Inaba M, "Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection" 107 : 195-200, 2021

      21 Udugama B, "Diagnosing COVID-19 : the disease and tools for detection" 14 : 3822-3835, 2020

      22 Russo A, "Current status of laboratory diagnosis for COVID-19 : a narrative review" 13 : 2657-2665, 2020

      23 Huergo MAC, "Current advances in the detection of COVID-19 and evaluation of the humoral response" 146 : 382-402, 2021

      24 Czodrowski P, "Count on kappa" 28 : 1049-1055, 2014

      25 Dang Y, "Comparison of qualitative and quantitative analyses of COVID-19 clinical samples" 510 : 613-616, 2020

      26 Verhaegen B, "Comparison of droplet digital PCR and qPCR for the quantifcation of Shiga toxin-producing Escherichia coli in Bovine Feces" 8 : 157-, 2016

      27 Zhang L, "Clinical characteristics of COVID19-infected cancer patients : a retrospective case study in three hospitals within Wuhan, China" 31 : 894-901, 2020

      28 Xu M, "COVID-19 diagnostic testing : technology perspective" 10 : e158-, 2020

      29 Heungsup Sung, "COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays" 대한진단검사의학회 40 (40): 439-447, 2020

      30 Dhamad AE, "COVID-19 : molecular and serological detection methods" 8 : e10180-, 2020

      31 Garg D, "Beyond fever, cough and dyspnea : the neurology of COVID-19" 68 : 62-66, 2020

      32 Padoan A, "Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics" 58 : 1081-1088, 2020

      33 Kim KB, "Analytical and clinical performance of droplet digital PCR in the detection and quantifcation of SARS-CoV-2" 25 : 617-628, 2021

      34 Freire-Paspuel B, "Analytical and clinical evaluation of"AccuPower SARS-CoV-2 Multiplex RT-PCR kit(Bioneer, South Korea)"and"Allplex 2019-nCoV Assay(Seegene, South Korea)"for SARS-CoV-2 RT-PCR diagnosis : Korean CDC EUA as a quality control proxy for developing countries" 11 : 630552-, 2021

      35 Seegene, "AllplexTM 2019-nCoV Assay v 2.2 (Cat no. RP10250X/ RP10252W) instructions for use"

      36 Cao L, "Advances in digital polymerase chain reaction(dPCR)and its emerging biomedical applications" 90 : 459-474, 2017

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2012-05-07 학술지명변경 한글명 : 한국유전학회지 -> Genes & Genomics KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-04-14 학술지명변경 외국어명 : Korean Journal of Genetics -> Genes and Genomics KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.51 0.12 0.38
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.32 0.27 0.258 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼